Pinnacle Financial Group, Inc.’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Pinnacle Financial Group, Inc.'s REGN Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. reported 425 shares of Regeneron Pharmaceuticals (REGN) worth $322K in Q3 2026. The position accounts for 0.03% of the portfolio, ranked #361.
1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Pinnacle Financial Group, Inc. held 425 shares of Regeneron Pharmaceuticals worth $322K as of Q3 2026.
- Regeneron Pharmaceuticals made up 0.03% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #361 holding.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.